ResearcherColumbia UniversityNo recent work listed
Sunil Amin
Matched on ORCID iD 0000-0002-3067-4730; OpenAlex author ID A5082233642. Sources: OpenAlex.
Their work
- Papers
- 11 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 9
2012: 1 paper · 2013: 2 papers · 2014: none · 2015: none · 2016: 2 papers · 2017: none · 2018: none · 2019: 2 papers · 2020: none · 2021: 2 papers · 2022: 2 papers
Papers 11
- Use of endoscopic ultrasound for pancreatic cancer from 2000 to 2016. Co-author DOI 10.1055/a-1608-0856↗
- Opioid Prescription Is Associated With Increased Survival in Older Adult Patients With Pancreatic Cancer in the United States: A Propensity Score Analysis. Co-author DOI 10.1200/op.21.00488↗
- Beta-blockers have no impact on survival in pancreatic ductal adenocarcinoma prior to cancer diagnosis. Co-author DOI 10.1038/s41598-020-79999-0↗
- Bisphosphonate Use Does Not Impact Survival in Patients with Pancreatic Cancer: A Propensity Score Matching Analysis. Co-author DOI 10.5009/gnl20297↗
- Preoperative Endoscopic Retrograde Cholangiopancreatography Is Not Associated With Increased Pancreatic Cancer Mortality. First author DOI 10.1016/j.cgh.2018.11.056↗
- Age, socioeconomic features, and clinical factors predict receipt of endoscopic retrograde cholangiopancreatography in pancreatic cancer. First author DOI 10.4253/wjge.v11.i2.133↗
- Metformin Improves Survival in Patients with Pancreatic Ductal Adenocarcinoma and Pre-Existing Diabetes: A Propensity Score Analysis. Co-author DOI 10.1038/ajg.2016.288↗
- The Role of Common Pharmaceutical Agents on the Prevention and Treatment of Pancreatic Cancer. Co-author DOI 10.5009/gnl15451↗
- Advanced EUS imaging for early detection of pancreatic cancer. Co-author DOI 10.1016/j.giec.2013.03.001↗
- Evidence for treatment and survival disparities by age in pancreatic adenocarcinoma: a population-based analysis. Co-author DOI 10.1097/mpa.0b013e31825f3af4↗
- Incidence of subsequent pancreatic adenocarcinoma in patients with a history of nonpancreatic primary cancers. Co-author DOI 10.1002/cncr.26414↗
Closest collaborators
The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Aimee Lee Lucas · 10 shared papers, 2012–2022 · strength 1.09
- Paper Opioid Prescription Is Associated With Increased Survival in Older Adult Patients With Pancreatic Cancer in the United … DOI 10.1200/op.21.00488↗
- Paper Use of endoscopic ultrasound for pancreatic cancer from 2000 to 2016. DOI 10.1055/a-1608-0856↗
- Paper Beta-blockers have no impact on survival in pancreatic ductal adenocarcinoma prior to cancer diagnosis. DOI 10.1038/s41598-020-79999-0↗
- Sheila D. Rustgi · 6 shared papers, 2019–2022 · strength 0.83
- Paper Opioid Prescription Is Associated With Increased Survival in Older Adult Patients With Pancreatic Cancer in the United … DOI 10.1200/op.21.00488↗
- Paper Use of endoscopic ultrasound for pancreatic cancer from 2000 to 2016. DOI 10.1055/a-1608-0856↗
- Paper Beta-blockers have no impact on survival in pancreatic ductal adenocarcinoma prior to cancer diagnosis. DOI 10.1038/s41598-020-79999-0↗
- Haley M. Zylberberg · 4 shared papers, 2021–2022 · strength 0.63
- Paper Opioid Prescription Is Associated With Increased Survival in Older Adult Patients With Pancreatic Cancer in the United … DOI 10.1200/op.21.00488↗
- Paper Use of endoscopic ultrasound for pancreatic cancer from 2000 to 2016. DOI 10.1055/a-1608-0856↗
- Paper Beta-blockers have no impact on survival in pancreatic ductal adenocarcinoma prior to cancer diagnosis. DOI 10.1038/s41598-020-79999-0↗
- Paolo Boffetta · 5 shared papers, 2016–2021 · strength 0.51
- Paper Beta-blockers have no impact on survival in pancreatic ductal adenocarcinoma prior to cancer diagnosis. DOI 10.1038/s41598-020-79999-0↗
- Paper Age, socioeconomic features, and clinical factors predict receipt of endoscopic retrograde cholangiopancreatography in … DOI 10.4253/wjge.v11.i2.133↗
- Paper The Role of Common Pharmaceutical Agents on the Prevention and Treatment of Pancreatic Cancer. DOI 10.5009/gnl15451↗
- Anthony Yang · 3 shared papers, 2019–2021 · strength 0.39
- Paper Beta-blockers have no impact on survival in pancreatic ductal adenocarcinoma prior to cancer diagnosis. DOI 10.1038/s41598-020-79999-0↗
- Paper Bisphosphonate Use Does Not Impact Survival in Patients with Pancreatic Cancer: A Propensity Score Matching Analysis. DOI 10.5009/gnl20297↗
- Paper Preoperative Endoscopic Retrograde Cholangiopancreatography Is Not Associated With Increased Pancreatic Cancer Mortalit… DOI 10.1016/j.cgh.2018.11.056↗
- Satish Nagula · 3 shared papers, 2019–2022 · strength 0.36
- Paper Use of endoscopic ultrasound for pancreatic cancer from 2000 to 2016. DOI 10.1055/a-1608-0856↗
- Paper Age, socioeconomic features, and clinical factors predict receipt of endoscopic retrograde cholangiopancreatography in … DOI 10.4253/wjge.v11.i2.133↗
- Paper Preoperative Endoscopic Retrograde Cholangiopancreatography Is Not Associated With Increased Pancreatic Cancer Mortalit… DOI 10.1016/j.cgh.2018.11.056↗
- Harold Frucht · 2 shared papers, 2012–2013 · strength 0.09
- Michelle Kang Kim · 1 shared paper, 2013 · strength 0.06
- Alfred I. Neugut · 1 shared paper, 2012 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.